<SEC-DOCUMENT>0001640334-24-001132.txt : 20240717
<SEC-HEADER>0001640334-24-001132.hdr.sgml : 20240717
<ACCEPTANCE-DATETIME>20240717161218
ACCESSION NUMBER:		0001640334-24-001132
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20240715
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240717
DATE AS OF CHANGE:		20240717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexaria Bioscience Corp.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39874
		FILM NUMBER:		241122362

	BUSINESS ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7
		BUSINESS PHONE:		250-765-6424

	MAIL ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXARIA CORP.
		DATE OF NAME CHANGE:	20080229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrp_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:lxrp="http://lxrp.com/20240715"><head><title>lxrp_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-07-15to2024-07-15" id="ixv-286">0001348362</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-07-15to2024-07-15" format="ixt:booleanfalse" id="ixv-287">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="lxrp-20240715.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-07-15to2024-07-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-15</xbrli:startDate><xbrli:endDate>2024-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-15to2024-07-15_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-15</xbrli:startDate><xbrli:endDate>2024-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-15to2024-07-15_lxrp_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-15</xbrli:startDate><xbrli:endDate>2024-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2024-07-15to2024-07-15" id="ixv-323">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported) <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2024-07-15to2024-07-15" format="ixt:datemonthdayyearen" id="ixv-324">July 15, 2024</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:74%;vertical-align:top;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2024-07-15to2024-07-15" id="ixv-325">LEXARIA BIOSCIENCE CORP.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td colspan="6" style="width:74%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160; </p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:stateprovnameen" id="ixv-326">Nevada</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2024-07-15to2024-07-15" id="ixv-327">000-52138</ix:nonNumeric>&#160;</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2024-07-15to2024-07-15" id="ixv-328">20-2000871</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer Identification&#160;No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2024-07-15to2024-07-15" id="ixv-329">100 &#8211; 740 McCurdy Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2024-07-15to2024-07-15" id="ixv-330">Kelowna</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2024-07-15to2024-07-15" id="ixv-331">BC</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:countrynameen" id="ixv-332">Canada</ix:nonNumeric> </strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2024-07-15to2024-07-15" id="ixv-333">V1X 2P7</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code <strong><span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2024-07-15to2024-07-15" id="ixv-334">250</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2024-07-15to2024-07-15" id="ixv-335">765-6424</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:boolballotbox" id="ixv-336">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:boolballotbox" id="ixv-337">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:boolballotbox" id="ixv-338">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:boolballotbox" id="ixv-339">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title of each class</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trading </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Symbol(s)</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name of each exchange on which registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_1_0" name="dei:Security12bTitle" contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember">Common Stock, par value $0.001 per share</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_2_0" name="dei:Security12bTitle" contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember">Warrants to Purchase Common Stock</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_1_1" name="dei:TradingSymbol" contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember">LEXX</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_2_1" name="dei:TradingSymbol" contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember">LEXXW</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric id="aid_1_2" name="dei:SecurityExchangeName" contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric id="aid_2_2" name="dei:SecurityExchangeName" contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Emerging growth company&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2024-07-15to2024-07-15" format="ixt-sec:boolballotbox" id="ixv-346">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 5.02</strong> <strong>Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective on July 15, 2024, Mr. Nelson Cabatuan resigned from his position as the Company&#8217;s Chief Financial Officer in order to focus his attention on corporate finance and strategic industry relationships for Lexaria as its Chief Strategic Financial Advisor.&#160; Mr. Cabatuan&#8217;s resignation is not due to any disagreement with the Company or any matter relating to the Company&#8217;s operations, financial statements, internal controls, auditors, policies or practices.&#160; Pursuant to his resignation as CFO, effective on July 15, 2024, the 150,000 unvested options that were issued as part of Mr. Cabatuan&#8217;s 200,000 option issuance as CFO will expire and be returned to the Company&#8217;s Incentive Equity Compensation Plan for reissuance.&#160; In addition, Mr. Cabatuan has agreed to reduce the term of his vested 50,000 options from March 15, 2029 to July 15, 2026.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company expects to appoint and announce its new Chief Financial Officer in due course.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 7.01</strong> <strong>Regulation FD Disclosure</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 17, 2024 the Company announced initial results from eight of its twelve arm animal study WEIGHT-A24-1 whereby it has been found that DehydraTECH works with a second GLP-1 drug, liraglutide, works with semaglutide both with and without SNAC technology and that DehydraTECH-CBD is performing strongly against these GLP-1 drugs.&#160; The results from the initial eight study arms which tested DehydraTECH enhanced: CBD, Rybelsus&#174;, semaglutide and liraglutide were used to determine the strongest performers for the purposes of creating a combined DehydraTECH-semaglutide with DehydraTECH-CBD formulation and a combined DehydraTECH-liraglutide with DehydraTECH-CBD for the second portion of the study which has commenced with results expected to be completed in mid-October.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01</strong>&#160;<strong>Financial Statements and Exhibits</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:9%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">99.1</a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">Press Release dated July 17, 2024</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>LEXARIA BIOSCIENCE </strong><strong>CORP.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Chris Bunka</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Chris Bunka</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">CEO, Principal Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: July 17, 2024&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lxrp_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>lxrp_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img3.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Positive Interim Body Weight Results from Lexaria&#8217;s Diabetes Animal Study</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>DehydraTECH appears to work with a second GLP-1 drug &#8211; liraglutide</em></p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>DehydraTECH appears to be working with semaglutide both with and without SNAC technology</em></p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>DehydraTECH-CBD is showing strong apparent performance relative to GLP-1</em></p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Dosing in the final four study arms has now begun</em></p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Kelowna, British Columbia &#8211; July 17, 2024</strong> &#8211; Lexaria Bioscience Corp. (Nasdaq: LEXX &amp; LEXXW) (the &#8220;Company&#8221; or &#8220;Lexaria&#8221;), a global innovator in drug delivery platforms announces that interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1 (the &#8220;Study&#8221;) have been received and have already produced several noteworthy findings.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Unlimited food and water has been provided to the animals for the entire duration of the Study.&nbsp; During the initial acclimation phase of 34 days <em>before</em> the beginning of dosing, the animals gained 10.9% body weight on average. During the subsequent 28 days of DehydraTECH-processed drug therapy dosing, all test articles showed either a stark decrease in the rate of body weight gain or, in select cases, the beginning of body weight reduction. DehydraTECH-CBD formulation 3 (&#8220;CBD3&#8221;) and DehydraTECH-liraglutide have produced the largest weight loss results thus far of -1.50% and -1.58%, respectively. Of note, only in Study arms A, B, C, and E did any individual animals lose 5.0% or more body weight during these first 28 days of treatment. An additional 56 days of dosing remains across all treatment groups.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Animal Weights (grams)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;text-align:justify;width:100%" cellpadding="1"> <tr style="height:15px"> <td style="border-top:#000000 1px solid;border-left:#000000 1px solid;padding:1px;width:15%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>DehydraTECH Groups</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Arrival in Lab</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>End of Acclimation Period</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:bottom; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>% Change to End of Acclimation</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>End of 28 Days of Dosing</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:bottom; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>% Change to Day 28</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>A: CBD1</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">386.0</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">427.9</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+10.9%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">432.6</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+0.96%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>B: CBD2</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">360.6</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">394.6</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+9.4%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">393.3</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">-0.59%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>C: CBD3</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">375.5</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">416.0</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+10.8%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">408.8</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">-1.50%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>D: CBD4</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">377.2</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">431.2</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+14.3%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">431.7</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+0.32%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>E: Rybelsus1</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">365.1</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">394.9</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+8.2%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">394.6</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+0.07%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>F: Rybelsus2</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">364.5</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">406.2</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+11.4%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">409.1</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+0.72%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>G: Semaglutide</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">352.7</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">394.2</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+11.8%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">394.8</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+0.16%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>H: Liraglutide</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">354.6</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">392.2</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">+10.6%</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">385.7</p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">-1.58%</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:15%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Average</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>367.0</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>407.1</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>+10.9%</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:13%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>406.3</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;border-left:#000000 1px solid;padding-right:1px;padding:1px;width:12%;vertical-align:top; background-color:#d9d9d9;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>-0.18%</strong></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Notes</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">-Weights shown are average of six animals per group.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">- Groups A through D were varying DehydraTECH-CBD compositions </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">- Groups E and F were reformulated Rybelsus&#174; compositions including DehydraTECH and the sodium salcaprozate (&#8220;SNAC&#8221;) technology</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">- Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) without SNAC inclusion</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img4.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This is the first time that DehydraTECH processing was applied to the GLP-1 drug liraglutide, and it is encouraging to witness its relative outperformance. Although liraglutide was administered as an oral DehydraTECH-enabled dose in this Study, it is currently only sold and prescribed as a subcutaneous injection (see below for more context). Liraglutide is currently available commercially by Novo Nordisk&#174; sold under the brand names Victoza&#174; and Saxenda&#174;, but the <u>related patents have begun to expire</u> and open the door to new competitors. For example, Teva Pharmaceutical Industries Ltd&#174; recently <u>launched the first generic injectable version</u> of this GLP-1 drug. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Study arm G is the first time that pure semaglutide was tested with DehydraTECH processing without the SNAC technology found within the Rybelsus&#174; tablets. It is of interest that it has, so far, apparently performed nearly identically in body weight gain attenuation to Study arm E which is the best performing DehydraTECH-processed reformulated Rybelsus&#174; composition that includes the SNAC technology.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="lxrp_ex991img2.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Another important objective has now been reached in evaluating the results of the first 28 days of dosing among the first eight Study arms that, together, constitute Cohort 1 of the Study: Performance superiority has been observed among the various formulations, allowing the Study team to select the best performers for inclusion in the subsequent Cohort 2 Study work. Dosing in those final four Study arms that constitute Cohort 2 of the Study has begun and is expected to be completed in mid-October.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img5.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Those final four Study arms include a positive control arm (commercially available Rybelsus&#174;) and a placebo arm, as well as a combined DehydraTECH-semaglutide with DehydraTECH-CBD arm (Groups C + E), and a combined DehydraTECH-liraglutide with DehydraTECH-CBD arm (Groups C + H).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In all cases and as per design in an exploratory, directionally informative Study of this nature, animal populations were not intended to be large enough to necessarily evidence statistical significance, and readers are reminded that these data are indicative only of apparent trends that have not been analysed statistically. Blood glucose data for the first four weeks of dosing has also been received, is being processed, and will be released soon. Pharmacokinetic (&#8220;PK&#8221;) data for the first four weeks has not arrived yet and will be released when available. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Brain absorption data can only be collected at the end of the 12-week study and will also be released when available.&nbsp; Readers are encouraged to <u>review our May 17, 2024 press release</u> that provides a thorough explanation of the comprehensive Study design and rationale, including why possible enhancement of brain absorption is believed to be of potential significance.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>About Liraglutide</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Liraglutide is owned by Novo Nordisk&#174; and sold under the Victoza&#174; and Saxena&#174; brands which <u>generated $1.6 billion in combined revenue</u> in 2022. Liraglutide is currently administered only by injection, after attempts to utilize the SNAC technology found in semaglutide (and sold as the oral tablet Rybelsus&#174;) failed to deliver sufficient performance to enable an oral form factor. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><u>Previous investigators reported</u> that &#8220;the absorption enhancing action of SNAC is thought to be highly dependent on the specific agent it is enhancing, which means that carefully tailored co-formulation is required rather than co-administration. The structure of liraglutide (a structurally distinct analog of GLP-1RA) was found to be unfavorable for co-formulation with SNAC on account of its stronger membrane-binding properties, which reduced transcellular passage, as well as its greater tendency to oligomerize, which countered the monomerizing effects of SNAC. In a preclinical study, plasma exposure was significantly higher for semaglutide than liraglutide after oral dosing with SNAC.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>About the Study</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Study WEIGHT-A24-1 is underway using diabetic, pre-conditioned Zucker rats.&nbsp; Each arm of the Study is expected to be dosed for a 12-week period following the initial acclimation period. During the Study, over 1,500 blood plasma samples will be collected from the total rat population of 72 animals for purposes of detailed PK drug delivery analyses. Body weight and blood glucose readings were taken prior to Study start continuing at regular intervals during and at conclusion of the dosing period. Upon completion of the Study, brain tissue will be analysed to help determine whether DehydraTECH processing results in higher brain absorption than non-DehydraTECH arms, as Lexaria has evidenced numerous times in previous similar animal studies. The Study will also include a comprehensive battery of liver and kidney function testing and blood chemistry analyses. <u>LC-MS/MS</u> and other techniques will be used to analyse samples. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img6.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>About Lexaria Bioscience Corp. &amp; DehydraTECH</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">DehydraTECH&#8482; is Lexaria&#8217;s patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 46 patents granted and many patents pending worldwide. For more information, please visit <u>www.lexariabioscience.com</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the company relating the Company&#8217;s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements.&nbsp; As such, you should not place undue reliance on these forward-looking statements.&nbsp; Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company&#8217;s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&amp;D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria&#8217;s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA).&nbsp; Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>INVESTOR CONTACT:</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>George Jurcic - Head of Investor Relations</strong><strong> </strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><u>ir@lexariabioscience.com</u> </p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Phone: 250-765-6424, ext 202</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrp-20240715.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:lxrp="http://lxrp.com/20240715" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lxrp.com/20240715">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://lxrp.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240715_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240715_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240715_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240715_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
  <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <element name="WarrantsMember" id="lxrp_WarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrp-20240715_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address Country</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_c228a7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_c228a7" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_e49412" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_e49412" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl_1cefda" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl_1cefda" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="lxrp-20240715.xsd#lxrp_WarrantsMember" xlink:label="lxrp_WarrantsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lxrp_WarrantsMember" xlink:to="lxrp_WarrantsMember_lbl_1e3d62" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lxrp_WarrantsMember_lbl_1e3d62" xml:lang="en-US">Warrants</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>lxrp-20240715_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240715.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lxrp-20240715_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240715.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="loc_deiDocumentInformationTable" />
    <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentInformationTable" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
    <link:presentationArc order="501" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationTable" xlink:to="loc_deiDocumentInformationLineItems" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_f5aa5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementEquityComponentsAxis_f5aa5c" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_2e2c32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_f5aa5c" xlink:to="loc_us-gaapEquityComponentDomain_2e2c32" order="71" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_ab010f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementClassOfStockAxis_ab010f" order="91" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_2e84be" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_ab010f" xlink:to="loc_us-gaapClassOfStockDomain_2e84be" order="92" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_74f196" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_2e2c32" xlink:to="loc_us-gaapCommonStockMember_74f196" order="193" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240715.xsd#lxrp_WarrantsMember" xlink:label="loc_lxrpWarrantsMember_9f9b76" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_2e84be" xlink:to="loc_lxrpWarrantsMember_9f9b76" order="194" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lxrp-20240715_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240715.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="loc_deiDocumentInformationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiDocumentInformationTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiDocumentInformationTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="70" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" order="193" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240715.xsd#lxrp_WarrantsMember" xlink:label="loc_lxrpWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lxrpWarrantsMember" order="194" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>lxrp_ex991img6.jpg
<TEXT>
begin 644 lxrp_ex991img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W &L# 2(  A$! Q$!_\0
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E.!H5**>>0,8'4_G5J"UAM[=(;>SB2)!A5C4*H'L.U%%4*Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lxrp_ex991img2.jpg
<TEXT>
begin 644 lxrp_ex991img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" %S G # 2(  A$! Q$!_\0
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M\_\ UR;^5 !9_P#(/@_ZY+_*K-5K/_D'P?\ 7)?Y59H **** "BBB@ HHHH
MXOX4_P#)$/ ?_8OV'_I,E=I7%_"G_DB'@/\ [%^P_P#29*[2@ HHHH ****
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M^DR4 =I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4*UQ>Z=#/(0.@W,I.!5W0_#GA[PW:RVGAS0[#1K>1_,>&PM4MT=L ;B$ !.
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MK:UV= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/.CB6%#!>30!%#!AM$;@ @@'(YX% %.Q\3ZA>K: :79AKF&ZE1HK[S8RT3
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M_HA*Z*N=\%_\DY\-?]@FS_\ 1"5-#_D55?\ %'\F#^-'0]JYGXA?\DI\6_\
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M_P#TITVNSH **** "BBB@ HHHH **** "BBB@ HHHH **** "JUY_P @^?\
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M6GM_PQXU"I"G3G&2NY*V^VJ?8*#10:6)_@LSP2_?Q/I+X8_\DA\'?]@6R_\
M2=*['_@-<=\+_P#DDG@W_L"V7_I.E9GQ0\>3?#OP]I^J0:.NKRWM\MDL+W!M
MPN8I)"Q8(_:+&-O>ORF492ERQ5VS]XI24:?-)V2/1>:.:^;/^&FM5_Z$&S_\
M'3__ "+1_P -,:M_T(5G_P"#I_\ Y%KI^HXC^1F?URC_ #(]?U+_ )+9X7_[
M &K_ /I3IM=GFODR[_: U>X\>Z/KA\#6@:STZ]M!!_;#$.)9;5BV[[/QCR0,
M8.=QY&.>A_X:8U;_ *$&S_\ !T__ ,BT+!8AWM!E/%T5:\EJ?25' ]J^;?\
MAIK6/^B?V7_@[?\ ^1:]/^%_CR;XA>'M0U2XT9-(FL[YK)H$N3<!L11R!@Q1
M.TN,;>U95<-5HQYJD6D53KTZKY8239Z-1116!TA1110 4444 %%%% !1110
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M[?BA_P ]/"__ (*+G_Y+K@J*[?JE'^7\S3V<>QWO_"[?BA_ST\+_ /@HN?\
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M54OM4'HJJ,G&:]SI,UH<AXE_PHS_ *A_PR_\(3_[LH_X49_U#_AE_P"$)_\
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MPBA[&5KWOHGM;N>@_P#"[OB1_>\.?^"VX_\ DJG_ /"[OB/_ 'O#W_@KN/\
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MB_8?^DR5VE<7\*?^2(> _P#L7[#_ -)DH [2BBB@ KS6;_DMGB'_ + &E?\
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M **** "BBB@ HHHH XOX4_\ )$/ ?_8OV'_I,E=I7%_"G_DB'@/_ +%^P_\
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MR7_<J?S_ #)****W/<"BBB@ JM>?\@^?_KDW\JLU6O/^0?/_ -<F_E0 6?\
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M_A?_ +%_5_\ TITVNSKC-2_Y+?X7_P"Q?U?_ -*=-H [.BBB@ HHHH ****
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MN[@2K<O9K9K"@15$:Q(Q4#@DD8R3SZUW%% !1110!Q?PI_Y(AX#_ .Q?L/\
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M HHHH *K7G_(/G_ZY-_*K-5KS_D'S_\ 7)OY4 %G_P @^#_KDO\ *K-5K/\
MY!\'_7)?Y59H ***\^\9?\+<_MJS_P"%>_\ ")_V7Y8^U?V[]J\[?N.=GE?+
MC;CKSF@"_JTOCVZ\2R:?H4.EZ7I<5NDHU:_C:\\^4LP,2V\<D3+M !+E\'<
M ><4?AIXPU;QAX>U*;6K&V@O-,U2XTMY[,L;:\,+!3-%NR0I.1@DX*GDU)KW
M_"*>,]6O? &H:I=?VC:6Z7=Q96=]<6<GE2;E#$Q,GF+URN6 .W(Y%<Y\"[[4
M)O#'B#1YKPZAI.AZW<Z7I%Z8U7S[2/:%&5 #[3N7<.N/:@#U^BBN-OO"^NW5
M]/<6_P 1O$=A%(Y9;:W@TXQQ _PJ7M&; _VF)]Z &_"G_DB'@/\ [%^P_P#2
M9*[2L'P[H]KX;\-:5X=L&FEM-*M(;*%YB"[)&@12Q  )PHS@#GM6]0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45Q7Q"\67O@GP@^N:?HK:[>M=6]I#8+<" S232K$HWE6QRP[?E0!VM%>._\
M"T/'7_"TD^'9\!Z)_:[Z7_:PD_X2*7R1%OV;=WV+._/;&/>NP\ ^*K[QEX07
M6=3T,Z'?)=7%I/8FX\\PR0RM$PWA5SRI[?G0!V5%%% !116-KVO:7X8T&]U[
M7;P6>FV,9EGF*,^Q?7"@D_0 F@#9HJ&*9)H4EC;<CJ&4],@]*FH **** "BB
MB@ HK F\0Z3#XLMO#,E]MU:YM7O(K7RV):)&"LV[&T<L!@G)[=#6_0 4444
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M^Q-/_I34_P 7CKEKXZ^',WA_7]0TJ[U+5CI\P2\E^S/'Y3L"]N&\MR#SR.<
M$XQC;?X;^(&^.Z?$X>+;$1I9?V8--_LEO^/;?O(\WS_]9G^+;C_9JQX^\!Z]
MXN\1^%M8TOQ-9Z0OAZ[^W10SZ6UUYLV"OS,)H\)M., 9[Y] #B/&L?BOX/\
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MKN/$'@'Q!K7Q/\*>-8_%%A:KX>26,61TEG%QYRA9B7\\;<@?+P=IZ[^E2S>
M]8TOQMJ_BKP;K]KI,NMB,ZC9ZAI[7MO+*@VK,@2:)D?;P?F(/IGF@#RO5=:\
M:77[*WBO4->O?$>EZWX>N9H]/U*3[3I=U=PHZB&9U&PON1\'(P2,D;AFMWQD
MVM^$XOAAXFL?%&LS:EJ>MV&F:BL]Y(]M=PSJ=X-N3Y2D8X95#=R6/-=QXX\$
MZYXT^&.H>#9/%4=O<:GA;J^ETT2 1\$I%&LB;>0,%F<@9!R2",KQ5\-?%'BK
MP]X.TUO&6GVD_AR^@U%K@:.[K=3P<1?)]I&Q<$[ADDGH5Z4 <QK?A;2[_P#:
MWLHY9]6C^V>&)KF5[?6+R!]PN% "M'*I1,?P*0F><9YKW"WLX[6UAM86E:.)
M!&IFE:5R ,#<[$LQ]222>YKB]>\!ZGJ7C[1O'FA^((=*UK3[.33[@3V)N;>Z
M@<[B-@E1D(;Y@=Q[9!KM;6*6UMH89KE[N5$"O,ZJK2$#EB%  )]@!0!HT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5KS_D'S_\ 7)OY59JM>?\ (/G_ .N3?RH Y"'6=26%56XPJH,#8O'Z
M58_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2
M_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\
M"BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+
M_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\
M<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[
M:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%
M_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_M
MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?
MG_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@
M _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_
M\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"
MC^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_
M )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *
M** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^
M?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ
M?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK
M4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_
M  HHH /[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM
M2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?
M_'%_PH_MK4O^?G_QQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #
M^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  HHH /[:U+_ )^?_'%_PH_MK4O^?G_Q
MQ?\ "BB@ _MK4O\ GY_\<7_"C^VM2_Y^?_'%_P *** #^VM2_P"?G_QQ?\*K
3S:SJ30LK7&59#D;%Y_2BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lxrp_ex991img3.jpg
<TEXT>
begin 644 lxrp_ex991img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W &L# 2(  A$! Q$!_\0
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E.!H5**>>0,8'4_G5J"UAM[=(;>SB2)!A5C4*H'L.U%%4*Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>lxrp_ex991img4.jpg
<TEXT>
begin 644 lxrp_ex991img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W &L# 2(  A$! Q$!_\0
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E.!H5**>>0,8'4_G5J"UAM[=(;>SB2)!A5C4*H'L.U%%4*Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>lxrp_ex991img5.jpg
<TEXT>
begin 644 lxrp_ex991img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W &L# 2(  A$! Q$!_\0
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E.!H5**>>0,8'4_G5J"UAM[=(;>SB2)!A5C4*H'L.U%%4*Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140019624666928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 15, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LEXARIA BIOSCIENCE CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001348362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 15,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-52138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2000871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">100 &#8211; 740 McCurdy Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Kelowna<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">V1X 2P7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-6424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Warrants to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LEXXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LEXX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "(@?%8!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M (B!\5A\IM_\[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( (B!\5B97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ B('Q6'XZ
M%9W>!   BQ4  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( (B!\5B?H!OPL0(  .(,   -
M  "  2$-  !X;"]S='EL97,N>&UL4$L! A0#%     @ B('Q6)>*NQS
M$P(   L              ( !_0\  %]R96QS+RYR96QS4$L! A0#%     @
MB('Q6*K$(A8S 0  (@(   \              ( !YA   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( (B!\5@D'INBK0   /@!   :              "
M 482  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (B!
M\5AED'F2&0$  ,\#   3              "  2L3  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  '44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="lxrp_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lxrp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lxrp-20240715.xsd</File>
    <File>lxrp-20240715_cal.xml</File>
    <File>lxrp-20240715_def.xml</File>
    <File>lxrp-20240715_lab.xml</File>
    <File>lxrp-20240715_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="lxrp_8k.htm">lxrp_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lxrp_8k.htm": {
   "nsprefix": "lxrp",
   "nsuri": "http://lxrp.com/20240715",
   "dts": {
    "schema": {
     "local": [
      "lxrp-20240715.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "lxrp-20240715_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lxrp-20240715_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lxrp-20240715_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrp-20240715_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "lxrp_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 32,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://lxrp.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-15to2024-07-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-15to2024-07-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "lxrp_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://lxrp.com/20240715",
     "localname": "WarrantsMember",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001640334-24-001132-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001640334-24-001132-xbrl.zip
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M(?^Z,HE$@AF_T30Q, @HFRO-M/T6_$6*+)UYN2X&D-S+:9!'??$_4$L#!!0
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ME!N:D]G$^\'+)@M$K;#2C76*+65V^\"9_*3^;X/T$$E^[__F?U!+ P04
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M..!],!B+!;J>$,CU6U_Z1OOFLG73UX1(862+$K6 CI@Q$(S>&70(*J]&J/M
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M67X?8LR?$ED=0WH2SN//!IH6>\C6VAE -?S#[T.MQCF@B/:3B$EI0S+"0Y9
MF2( +002TH#9R1DAD^./?=(7LC YI3R12@C8Q(YG39E7926$'BSOE#5JVS)^
M8B\O8,7(::L2%B[V! 9!A*/-URHJ\%F;=?=24'=Q*D^O\3DUX'$#["?M3)@U
ML2:?.-'M]9;Y?>M\Y<:*@AHTT-&A8UZ:T>Y2[#>?$5;@=-3QY^1B'_LC3<A
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M.1LD?/,,S/Q0X/3LGR<7EQ_/V1'$+/VCR]Y7]/?+2H!"X4FA?Q0Z!)W89.]
M%R%U3BE:!TR?"Z?N*V#<;_8UP2L.I/Z?.Z.^V2SJ F;\-%*IZ+'N9KNYO;79
MW-KH;B!OY;B9OGCV^?MF9C>^;FYT'__0XN _4$L! A0#%     @ B('Q6&;Y
M@&_D!   9Q<  !$              ( !     &QX<G M,C R-# W,34N>'-D
M4$L! A0#%     @ B('Q6"'EQ(C; 0  BP,  !4              ( !$P4
M &QX<G M,C R-# W,35?8V%L+GAM;%!+ 0(4 Q0    ( (B!\5A-T3L<U0,
M 'D5   5              "  2$'  !L>')P+3(P,C0P-S$U7V1E9BYX;6Q0
M2P$"% ,4    " "(@?%8J,M(5A$'  !(0@  %0              @ $I"P
M;'AR<"TR,#(T,#<Q-5]L86(N>&UL4$L! A0#%     @ B('Q6#!H6/G-!0
M2#(  !4              ( !;1(  &QX<G M,C R-# W,35?<')E+GAM;%!+
M 0(4 Q0    ( (B!\5A&LCI6MA$  $9M   +              "  6T8  !L
M>')P7SAK+FAT;5!+ 0(4 Q0    ( (B!\5@I388?Z!<  ":A   .
M      "  4PJ  !L>')P7V5X.3DQ+FAT;5!+!08     !P ' , !  !@0@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>lxrp_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lxrp="http://lxrp.com/20240715"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrp-20240715.xsd" xlink:type="simple"/>
    <context id="From2024-07-15to2024-07-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
        </entity>
        <period>
            <startDate>2024-07-15</startDate>
            <endDate>2024-07-15</endDate>
        </period>
    </context>
    <context id="From2024-07-15to2024-07-15_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-15</startDate>
            <endDate>2024-07-15</endDate>
        </period>
    </context>
    <context id="From2024-07-15to2024-07-15_lxrp_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-15</startDate>
            <endDate>2024-07-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-07-15to2024-07-15" id="ixv-286">0001348362</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-07-15to2024-07-15" id="ixv-287">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-07-15to2024-07-15" id="ixv-323">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-07-15to2024-07-15" id="ixv-324">2024-07-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-07-15to2024-07-15" id="ixv-325">LEXARIA BIOSCIENCE CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-07-15to2024-07-15" id="ixv-326">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-07-15to2024-07-15" id="ixv-327">000-52138</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-07-15to2024-07-15" id="ixv-328">20-2000871</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-07-15to2024-07-15" id="ixv-329">100 &#x2013; 740 McCurdy Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-07-15to2024-07-15" id="ixv-330">Kelowna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-07-15to2024-07-15" id="ixv-331">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="From2024-07-15to2024-07-15" id="ixv-332">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2024-07-15to2024-07-15" id="ixv-333">V1X 2P7</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-07-15to2024-07-15" id="ixv-334">250</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-07-15to2024-07-15" id="ixv-335">765-6424</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2024-07-15to2024-07-15" id="ixv-336">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-07-15to2024-07-15" id="ixv-337">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-07-15to2024-07-15" id="ixv-338">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-07-15to2024-07-15" id="ixv-339">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember"
      id="aid_1_0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember"
      id="aid_2_0">Warrants to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember"
      id="aid_1_1">LEXX</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember"
      id="aid_2_1">LEXXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-07-15to2024-07-15_us-gaap_CommonStockMember"
      id="aid_1_2">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2024-07-15to2024-07-15_lxrp_WarrantsMember"
      id="aid_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-07-15to2024-07-15" id="ixv-346">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
